A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

JOURNAL ARTICLE published 15 March 2007 in Cancer

Authors: Alan K. Burnett | Donald Milligan | Archie G. Prentice | Anthony H. Goldstone | Mary F. McMullin | Robert K. Hills | Keith Wheatley